BioCardia, Inc.

BCDANASDAQHealthcare● Active

$0.92

$-0.11(-10.68%)

Market Cap$5334911

P/E Ratio—

52W High$2.45

52W Low$0.84

Avg Volume164K

Open$1.03

Beta0.50

Overview

BioCardia, Inc. (BCDA) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · BCDA · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

∞

Buy/Sell (by trades)

Overall sentiment

BULLISH

↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

BioCardia, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

BCDA insider buying and selling by quarter

BCDA insider selling · BCDA insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

1.5M736K0

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · BCDA ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

BCDA executive sell shares · BCDA board member insider trading · BCDA insider trading SEC filing

Showing 69 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
May 20, 2026	Altman Peter President and CEO · Director	Purchase	1,500	$0.92	$1K	293,266	Form 4
May 19, 2026	Altman Peter President and CEO · Director	Purchase	200	$0.95	$190	291,766	Form 4
May 18, 2026	Altman Peter President and CEO · Director	Purchase	5,700	$0.92	$5K	291,566	Form 4
May 15, 2026	Altman Peter President and CEO · Director	Purchase	5,100	$1.02	$5K	285,866	Form 4
Apr 29, 2026	Altman Peter President and CEO · Director	Purchase	5,000	$1.11	$6K	280,766	Form 4
Apr 21, 2026	Altman Peter President and CEO · Director	Purchase	400	$1.23	$492	275,766	Form 4
Apr 20, 2026	Altman Peter President and CEO · Director	Purchase	600	$1.23	$738	275,366	Form 4
Mar 25, 2026	Altman Peter President and CEO · Director	Purchase	300	$1.22	$366	274,766	Form 4
Mar 24, 2026	Altman Peter President and CEO · Director	Purchase	600	$1.24	$744	274,466	Form 4
Feb 4, 2026	Altman Peter President and CEO · Director	Purchase	5,000	$1.13	$6K	273,866	Form 4
Jan 21, 2026	Altman Peter President and CEO · Director	Purchase	300	$1.34	$402	268,866	Form 4
Jan 20, 2026	Altman Peter President and CEO · Director	Purchase	600	$1.32	$792	268,566	Form 4
Dec 17, 2025	Altman Peter President and CEO · Director	Purchase	900	$1.30	$1K	267,966	Form 4
Dec 16, 2025	Altman Peter President and CEO · Director	Purchase	200	$1.37	$274	267,066	Form 4
Dec 8, 2025	Altman Peter President and CEO · Director	Award	106,588	$1.37	$146K	323,350	Form 4
Dec 8, 2025	Altman Peter President and CEO · Director	Other	56,484	$1.37	$77K	266,866	Form 4
Dec 8, 2025	McClung David CFO	Award	58,276	$1.37	$80K	106,226	Form 4
Dec 8, 2025	McClung David CFO	Other	29,339	$1.37	$40K	76,887	Form 4
Dec 8, 2025	GILLIS EDWARD M Senior Vice President, Devices	Award	38,078	$1.37	$52K	47,046	Form 4
Dec 8, 2025	GILLIS EDWARD M Senior Vice President, Devices	Other	15,172	$1.37	$21K	31,874	Form 4
Sep 19, 2025	STERTZER SIMON H Director	Purchase	398,400	$1.25	$498K	591,054	Form 4
Sep 19, 2025	Blank Andrew Scott Director	Purchase	288,000	$1.25	$360K	634,023	Form 4
Sep 19, 2025	Altman Peter President and CEO · Director	Purchase	48,000	$1.25	$60K	216,762	Form 4
Aug 22, 2025	Altman Peter President and CEO · Director	Purchase	700	$1.83	$1K	168,762	Form 4
Aug 13, 2025	Altman Peter President and CEO · Director	Purchase	100	$1.83	$183	168,062	Form 4

Altman Peter

President and CEO · Director

Purchase

Date

May 20

1,500

Price

$0.92

Value

$1K

View Form 4 on SEC.gov

Altman Peter

President and CEO · Director

Purchase

Date

May 19

200

Price

$0.95

Value

$190

View Form 4 on SEC.gov

Altman Peter

President and CEO · Director

Purchase

Date

May 18

5,700

Price

$0.92

Value

$5K

View Form 4 on SEC.gov

Altman Peter

President and CEO · Director

Purchase

Date

May 15

5,100

Price

$1.02

Value

$5K

View Form 4 on SEC.gov

Altman Peter

President and CEO · Director

Purchase

Date

Apr 29

5,000

Price

$1.11

Value

$6K

View Form 4 on SEC.gov

Altman Peter

President and CEO · Director

Purchase

Date

Apr 21

400

Price

$1.23

Value

$492

View Form 4 on SEC.gov

Altman Peter

President and CEO · Director

Purchase

Date

Apr 20

600

Price

$1.23

Value

$738

View Form 4 on SEC.gov

Altman Peter

President and CEO · Director

Purchase

Date

Mar 25

300

Price

$1.22

Value

$366

View Form 4 on SEC.gov

Altman Peter

President and CEO · Director

Purchase

Date

Mar 24

600

Price

$1.24

Value

$744

View Form 4 on SEC.gov

Altman Peter

President and CEO · Director

Purchase

Date

Feb 4

5,000

Price

$1.13

Value

$6K

View Form 4 on SEC.gov

Altman Peter

President and CEO · Director

Purchase

Date

Jan 21

300

Price

$1.34

Value

$402

View Form 4 on SEC.gov

Altman Peter

President and CEO · Director

Purchase

Date

Jan 20

600

Price

$1.32

Value

$792

View Form 4 on SEC.gov

Altman Peter

President and CEO · Director

Purchase

Date

Dec 17

900

Price

$1.30

Value

$1K

View Form 4 on SEC.gov

Altman Peter

President and CEO · Director

Purchase

Date

Dec 16

200

Price

$1.37

Value

$274

View Form 4 on SEC.gov

Altman Peter

President and CEO · Director

Award

Date

Dec 8

106,588

Price

$1.37

Value

$146K

View Form 4 on SEC.gov

Altman Peter

President and CEO · Director

Other

Date

Dec 8

56,484

Price

$1.37

Value

$77K

View Form 4 on SEC.gov

McClung David

CFO

Award

Date

Dec 8

58,276

Price

$1.37

Value

$80K

View Form 4 on SEC.gov

McClung David

CFO

Other

Date

Dec 8

29,339

Price

$1.37

Value

$40K

View Form 4 on SEC.gov

GILLIS EDWARD M

Senior Vice President, Devices

Award

Date

Dec 8

38,078

Price

$1.37

Value

$52K

View Form 4 on SEC.gov

GILLIS EDWARD M

Senior Vice President, Devices

Other

Date

Dec 8

15,172

Price

$1.37

Value

$21K

View Form 4 on SEC.gov

STERTZER SIMON H

Director

Purchase

Date

Sep 19

398,400

Price

$1.25

Value

$498K

View Form 4 on SEC.gov

Blank Andrew Scott

Director

Purchase

Date

Sep 19

288,000

Price

$1.25

Value

$360K

View Form 4 on SEC.gov

Altman Peter

President and CEO · Director

Purchase

Date

Sep 19

48,000

Price

$1.25

Value

$60K

View Form 4 on SEC.gov

Altman Peter

President and CEO · Director

Purchase

Date

Aug 22

700

Price

$1.83

Value

$1K

View Form 4 on SEC.gov

Altman Peter

President and CEO · Director

Purchase

Date

Aug 13

100

Price

$1.83

Value

$183

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About BCDA insider trading

BCDA insider trades

BioCardia, Inc. (BCDA) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Altman Peter (President and CEO · Director), McClung David (CFO), GILLIS EDWARD M (Senior Vice President, Devices). Over the past 12 months, 5 insiders have filed transactions with the SEC. BCDA insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For BioCardia, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

BCDA insider trading · 5 questions

The insiders of BioCardia, Inc. (BCDA) include executives and directors such as Altman Peter (President and CEO · Director), McClung David (CFO), GILLIS EDWARD M (Senior Vice President, Devices), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

BCDA board member insider tradingwho are BCDA insidersBCDA insider rosterBioCardia, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026